<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: EBV has been associated with Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>It establishes a <z:e sem="disease" ids="C0872054" disease_type="Disease or Syndrome" abbrv="">latent infection</z:e> but its reactivation has been observed in patients receiving long-term chemotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>The effect of <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> on virus reactivation has been described previously, but the effect of <z:chebi fb="0" ids="4911">etoposide</z:chebi> or <z:chebi fb="0" ids="28680">cytarabine</z:chebi> on EBV reactivation has not been reported in the literature </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this work was to carry out such a study </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Akata EBV-positive cell lines were treated with <z:chebi fb="0" ids="4911">etoposide</z:chebi>, <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> or <z:chebi fb="0" ids="28680">cytarabine</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Viable cells were analyzed by trypan blue, programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> by TUNEL assay, <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels by RT-PCR and cellular or <z:mp ids='MP_0001799'>viral</z:mp> proteins by Western blot </plain></SENT>
<SENT sid="6" pm="."><plain>Viruses were visualized by electron microscopy </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> of the studied drugs caused cell <z:hpo ids='HP_0011420'>death</z:hpo> by <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>Comparing the effect of <z:chebi fb="0" ids="4911">etoposide</z:chebi> and <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> (at their IC(50)) in the EBV-positive cells, <z:chebi fb="0" ids="4911">etoposide</z:chebi> caused less EBV reactivation than <z:chebi fb="0" ids="28748">doxorubicin</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="28680">Cytarabine</z:chebi> apparently did not reactivate EBV </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: When treating Akata EBV-positive cells with the respective IC(50) of the following drugs, <z:chebi fb="0" ids="4911">etoposide</z:chebi> induced less EBV reactivation than <z:chebi fb="0" ids="28748">doxorubicin</z:chebi>, and <z:chebi fb="0" ids="28680">cytarabine</z:chebi> apparently did not induce EBV reactivation </plain></SENT>
</text></document>